Please login to the form below
ESMO congress
This page shows the latest ESMO congress news and features for those working in and with pharma, biotech and healthcare.
Imugene’s cancer vaccine shows promise in mid-stage stomach cancer trial
The new mid-stage data, presented at the ESMO World Congress on Gastrointestinal Cancer 2021 annual meeting, showed that HER-Vaxx plus chemotherapy resulted in an overall response rate of 50%
Latest news
-
AZ’s Tagrisso approved for EGFR-positive NSCLC in the EU
The results, presented at the 2020 European Society for Medical Oncology (ESMO) virtual congress, showed promise in this patient population, with patients in the treatment-naïve group achieving a 100% overall
-
BMS gains FDA approval for second Opdivo combo in kidney cancer
The results from this trial, presented at the 2020 European Society for Medical Oncology (ESMO) virtual congress, detailed a 40% reduction in the risk of death among previously untreated RCC patients
-
BMS’ Opdivo wins EU approval for second-line oesophageal cancer
In September, Merck presented results from the KEYNOTE-590 trial at the 2020 European Society for Medical Oncology (ESMO) virtual congress, which evaluated Keytruda in combination with chemotherapy in first-line ... Opdivo is also chasing approval in the
-
Merck, Eisai’s Keytruda plus Lenvima combo hits the mark in renal cancer
Data presented at the 2020 European Society for Medical Oncology (ESMO) virtual congress detailed a 40% reduction in the risk of death among previously untreated RCC patients receiving Opdivo plus Cabometyx
-
Lilly’s Verzenio scores a win in early-stage breast cancer
Positive data was presented at 2020 ESMO virtual congress. Eli Lilly’s Verzenio has scored positive results in early breast cancer, cutting the risk of disease recurrence by 25% when given
AZ’s Tagrisso approved for EGFR-positive NSCLC in the EU
BMS gains FDA approval for second Opdivo combo in kidney cancer
BMS’ Opdivo wins EU approval for second-line oesophageal cancer
Merck, Eisai’s Keytruda plus Lenvima combo hits the mark in renal cancer
Lilly’s Verzenio scores a win in early-stage breast cancer
More from news
Approximately 1 fully matching, plus 28 partially matching documents found.
Latest from PMHub
-
Creative review: ESMO 2018
BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring ... On October 19th the team from Blue Latitude Health
-
ESMO 2012 Video and Social Media Highlights
Brandcast Health's take on the highlights from the ESMO 2012 congress in Vienna, Austria, including social media insights.
-
Blue Latitude Health
As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. ... BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners
Blue Latitude Health
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
-
Digital strategist
-
Competitive
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Events Executive
-
Depending on Experience
-
Digital project manager
-
Competitive
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- Another Landmark Lucid Workiversary
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
No results were found
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
